Peter Culpepper
9 SlideShares 3 Seguidores
Personal Information
Organización/Lugar de trabajo
Knoxville, Tennessee United States
Ocupación
Chief Financial Operator and Chief Operating Officer
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
about.me/peterculpepper
Acerca de
Experienced in an array of financial and administrative matters, Peter Culpepper facilitates the growth of Provectus Biopharmaceuticals, Inc., a publicly traded company in its early stages. Under his leadership as the Chief Financial Officer and Chief Operating Officer, the company’s capital funding has increased from $1.5 million to over $50 million.
Datos de contacto
Etiquetas
peter culpepper pv-10 cancer provectus biopharmaceuticals cancer immunology university of maryland financial times list ranking mba program potential treatment colon cancer grading brain doctors new patent provectus treating melanoma kids rides pan-mass challenge cancers of the skin world congress society for immunotherapy cancer presentation melanoma medical medicine pete culpepper breast cancer certified public accountant metastatic melanoma responsibilities corporate controller cpa finance business profit and loss american cancer society chief financial officer cfo
Ver más

Presentaciones

(9)
Ver todo

Exploring Advanced Techniques for Breast Cancer Treatment with Provectus

Hace 10 años • 245 Visualizaciones

Peter culpepper the college of william and mary

Hace 10 años • 262 Visualizaciones

Society for Immunotherapy of Cancer Presentation on PV-10 and Melanoma

Hace 8 años • 258 Visualizaciones

Register for the 2016 World Congress on Cancers of the Skin

Hace 8 años • 160 Visualizaciones

Pan-Mass Challenge Kids Rides

Hace 8 años • 118 Visualizaciones

Provectus’ High-Profile Success with PV-10 in Treating Melanoma

Hace 8 años • 129 Visualizaciones

Provectus Biopharmaceuticals Secures New Patent

Hace 7 años • 110 Visualizaciones

Research Points to PV-10 as a Potential Treatment for Colon Cancer

Hace 7 años • 107 Visualizaciones

Provectus Biopharmaceuticals Presents PV-10 Cancer Immunology Data

Hace 7 años • 107 Visualizaciones
Personal Information
Organización/Lugar de trabajo
Knoxville, Tennessee United States
Ocupación
Chief Financial Operator and Chief Operating Officer
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
about.me/peterculpepper
Acerca de
Experienced in an array of financial and administrative matters, Peter Culpepper facilitates the growth of Provectus Biopharmaceuticals, Inc., a publicly traded company in its early stages. Under his leadership as the Chief Financial Officer and Chief Operating Officer, the company’s capital funding has increased from $1.5 million to over $50 million.
Etiquetas
peter culpepper pv-10 cancer provectus biopharmaceuticals cancer immunology university of maryland financial times list ranking mba program potential treatment colon cancer grading brain doctors new patent provectus treating melanoma kids rides pan-mass challenge cancers of the skin world congress society for immunotherapy cancer presentation melanoma medical medicine pete culpepper breast cancer certified public accountant metastatic melanoma responsibilities corporate controller cpa finance business profit and loss american cancer society chief financial officer cfo
Ver más